August 20, 2018
FDA issues Safety Alert for Temporary Total Artificial Heart Companion 2 Driver System by SynCardia Systems
Editor's Note
The Food & Drug Administration (FDA) on August 17 issued a Safety Alert for SynCardia Systems’ (Tucson, Arizona) Temporary Total Artificial Heart Companion 2 Driver System.
Final results from a post-approval study indicate higher mortality and stroke rates for patients initially supported with the C2 Driver System compared to patients initially supported with the previous generation driver, the Circulatory Support System Console.
The C2 Driver System was approved by the FDA in 2012.
Free Daily News
- Hospital safety grades show progress in reducing medical errors, infections
- Analysis: Overuse of back surgeries costs Medicare $2 billion, risks patient safety
- AI-powered surgical robot learns by watching
- AHA's Congressional "wish list" calls for financial relief, patient access, workforce protections
- Out-of-hospital cardiac arrest survival rates lag pre-pandemic levels, racial disparities persist
- Honoring the OR Manager Award winners this Perioperative Nurses Week
- Study: Demand for anesthesiologists rises sharply, driven by job market, regional variations
- Joint Commission Sentinel Event Alert details environmental disaster preparation
- ACS recognizes 77 hospitals for excellence in surgical outcomes
- Color-changing gel could enhance cataract surgery safety, efficiency
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement